Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Dexmedetomidine on Neurocognitive Function in Elderly ERCP Patients
NCT07497009Completed
- Sponsor
- Benha University
- Start
- Dec 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine and Lidocaine Hydrochloride Injection, without epinephrine in Post-operative cognitive dysfunction (POCD) (3 arms), sponsored by Benha University. Primary endpoint: Incidence of Postoperative Cognitive Dysfunction. Started Dec 2024; status: completed.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT07497009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07497009.